Denosumab Use in a Patient with Bisphosphonate-Resistant Humoral Hypercalcemia of Malignancy
Description
Figure 1: The response of the albumin-corrected calcium level of the patient to prednisone, zoledronic acid, and denosumab.
This image has been withdrawn.
